Abstract
We recently suggested that cyclophilin B (Cyp‐B) is a tumor antigen recognized by histocompatibility leukocyte antigen (HLA)‐A24‐restricted and tumor‐specific cytotoxic T lymphocytes (CTLs). In this study, we tried to identify Cyp‐B‐derived epitopes, which can induce HLA‐A2‐restricted and tumor‐specific CTLs in cancer patients. The tumor‐infiltrating lymphocytes (TILs) from an HLA‐A0207 patient with colon cancer were found to respond to COS‐7 cells when co‐transfected with the Cyp‐B gene and either HLA‐A0201, ‐A0206, or ‐A0207 cDNA. These TILs contained CTLs capable of recognizing either the Cyp‐B129–138 or the Cyp‐B172–179 peptide among 28 different peptides, all of which were prepared based on the HLA‐A2 binding motif. Both Cyp‐B peptides possessed the ability to induce tumor‐specific CTLs in HLA‐A2+ cancer patients. Cyp‐B172–180 (v), which is a 9‐mer peptide with valine added at the C terminus, showed no clear superiority over the parental Cyp‐B172‐179 peptide in an in vitro sensitization experiment. In vitro ‐sensitized T cells with these peptides responded to cancer cells in an HLA‐A2‐restricted manner. These two Cyp‐B peptides could be useful for specific immunotherapy of HLA‐A2+ cancer patients.
Keywords: Cyclophilin B, Cytotoxic T lymphocytes, Peptide, HLA‐A2
Full Text
The Full Text of this article is available as a PDF (113.8 KB).
Reference
- 1.Rosenberg , S. A . A new era for cancer immunotherapy based on the genes that encode cancer antigens . Immunity , 10 , 281 – 287 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 2.Marchand , M. , Weynants , P. , Rankin , E. , Arienti , F. , Belli , F. , Parmiani , G. , Cascinelli , N. , Bourlond , A. , Vanwijck , R. , Knuth , A. , Jager , F. , Brasseur , F. , Herman , J. , Coulie , P. G. and Boon , T . Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE‐3. Int . J. Cancer , 63 , 883 – 885 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 3.Rosenberg , S. A. , Yang , J. C. , Schwartentruber , D. J. , Hwu , P. , Marincola , F.M. , Toplalian , S.L. , Restifo , N.P. , Dudley , M. E. , Schwarz , S. L. , Spiess , P. J. , Wunderlich , J. R. , Parkhurst , M. A. , Kawakami , Y. , Seipp , C. A. , Einhorn , J. H. and White , D. E . Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma . Nat. Med. , 4 , 321 – 327 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shichijo , S. , Nakao , M. , Imai , Y. , Takasu , H. , Kawamoto , M. , Niiya , F. , Yang , D. , Toh , Y. , Yamana , H. and Itoh , K . A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes . J. Exp. Med. , 187 , 277 – 288 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gomi , S. , Nakao , M. , Niiya , F. , Imamura , Y. , Kawano , K. , Nishizaka , S. , Hayashi , A. , Sobao , Y. , Oizumi , K. and Itoh , K . A cyclophilin B gene encodes antigenic epitopes recognized by HLA‐A24‐restricted and tumor‐specific cytotoxic T lymphocytes . J. Immunol. , 163 , 4994 – 5004 ( 1999. ). [PubMed] [Google Scholar]
- 6.Yang , D. , Nakao , M. , Shichijo , S. , Sasatomi , T. , Takasu , H. , Matsumoto , H. , Mori , K. , Hayashi , A. , Yamana , H. , Shirouzu , K. and Itoh , K . Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA‐A24‐restricted cytotoxic T lymphocyte in cancer patients . Cancer Res. , 59 , 4056 – 4063 ( 1999. ). [PubMed] [Google Scholar]
- 7.Nakao , M. , Shichijo , S. , Imaizumi , T. , Inoue , Y. , Matsunaga , K. , Yamada , A. , Kikuchi , K. , Tsuda , N. , Ohta , K. , Takemori , S. , Yamana , H. , Fujita , H. and Itoh , K . Identification of a gene encoding for a new squamous cell carcinoma antigen recognized by the CTL . J. Immunol. , 164 , 2565 – 2574 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 8.Kawano , K. , Gomi , S. , Tanaka , K. , Tsuda , N. , Kamura , T. , Itoh , K. and Yamada , A . Identification of a new endoplasmic reticulum‐resident protein recognized by HLA‐A24‐restrictedtumor‐infiltratinglymphocytesof lung cancer . Cancer Res. , 60 , 3550 – 3558 ( 2000. ). [PubMed] [Google Scholar]
- 9.Imanishi , T. , Akazawa , T. , Kimura , A. , Tokunaga , K. and Gojobori , T . Allele and haplotype frequencies for HLA and complement loci in various ethnic groups . In “ HLA,” 1991 , Vol. 1 ( 1992. ). Oxford Scientific Publications; , Oxford . [Google Scholar]
- 10.Tokunaga , K. , Ishikawa , Y. , Ogawa , A. , Wang , H. , Mitsunaga , S. , Moriyama , S. , Lin , L. , Bannai , M. , Watanabe , Y. , Kashiwase , K. , Tanaka , H. , Akaza , T. , Tadokoro , K. and Juji , T . Sequence‐based association analysis of HLA class I and class II alleles in Japanese supports conservation of common haplotypes . Immunogenetics , 46 , 199 – 205 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 11.Browning , M. and Krause , P . Genetic diversity of HLA‐A2:evolutionary and functionalsignificance . Immunol. Today , 17 , 165 – 170 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 12.Toh , U. , Yamana , H. , Nakao , M. , Imai , Y. , Seki , N. , Takasu , H. , Kaneshige , T. , Fujita , H. , Shirouzu , K. and Itoh , K . HLA class I‐restricted and tumor‐specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers . Cell. Immunol. , 177 , 137 – 143 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 13.Ito , M. , Shichijo , S. , Miyagi , Y. , Kobayashi , T. , Tsuda , N. , Yamada , A. , Saito , N. and Itoh , K . Identificationof S ARTS‐derivedpeptidescapableof inducingHLA‐A2‐restricted and tumor‐specific CTLs in cancer patients with different HLA‐A2 subtypes . Int. J. Cancer , 88 , 633 – 639 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 14.Nakao , M. , Yamana , H. , Imai , Y. , Toh , Y. , Toh , U. , Kimura , A. , Yanoma , S. , Kakegawa , T. and Itoh , K . HLA‐A2601‐restricted CTLs recognized a peptide antigen expressed on squamous cell carcinoma . Cancer Res. , 55 , 4248 – 4252 ( 1995. ). [PubMed] [Google Scholar]
- 15.Parker , K. C. , Bednarek , M. A. and Coligan , J. E . Scheme for ranking potential HLA‐A2 peptides based on independent binding of individual peptide side‐chains . J. Immunol. , 152 , 163 – 175 ( 1994. ). [PubMed] [Google Scholar]
- 16.Rammensee , H.‐G. , Friede , T . and Stevanovic, S.MHC ligands and peptide motifs . Immunogenetics , 41 , 178 – 228 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 17.Sudo , T. , Kamikawaji , N. , Kimura , A. , Date , Y. , Savoie , C. J. , Nakashima , H. , Furuichi , E. , Kuhara , S. and Sasazuki , T . Difference in MHC class I self peptide repertoires among HLA‐A2 subtypes . J. Immunol. , 155 , 4749 – 4756 ( 1995. ). [PubMed] [Google Scholar]
- 18.Barouch , D. , Friede , T. , Stevanovic , S. , Tussey , L. , Smith , K. , Rowland‐Jones , S. , Braud , V. , McMichael , A. and Rammensee , H. G . HLA‐A2 subtype are functionally distinct in peptide binding and presentation . J. Exp. Med. , 182 , 1847 – 1856 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Price , E. R. , Zydowsky , L. D. , Jin , M. , Baker , H. , McKeon , F. D. and Walsh , C. T . Human cyclophilin B: a second cyclophilin gene encodes a peptidyl‐prolyl isomerase with a signal sequence . Proc. Natl. Acad. Sci.USA , 88 , 1903 – 1907 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bergsma , D. J. , Eder , C. , Gross , M. , Kersten , H. , Sylvester , D. , Appelbaum , E. , Cusimano , C. , Dunnington , D. , Hand , A. , Prichett , W. P. , Bossard , M. J. , Brandt , M. and Levy , M. A . The cyclophilin multigene family of peptidyl‐prolyl isomerases . J. Biol. Chem. , 266 , 23204 – 23214 ( 1991. ). [PubMed] [Google Scholar]
- 21.Bram , R. J . and Crab tree , G. R . Calcium signaling in T cells stimulated by a cyclophilin B‐binding protein . Nature , 371 , 355 – 358 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 22.Pflugl , G. , Kallen , J. , Schirmer , T. , Jansonius , J. N. , Zurini , M. G . and Walkinshaw , M.D . X‐raystructureof a decameric cyclophilin‐cyclosporin crystal complex . Nature , 361 , 91 – 94 ( 1993. ). [DOI] [PubMed] [Google Scholar]